larynx cancer (Cancer)

Search with Google Search with Bing
Information
Disease name
larynx cancer
Disease ID
DOID:2596
Description
"A respiratory system cancer that is located_in the larynx." [url:http\://en.wikipedia.org/wiki/Larynx]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID Status Phase Summary Start date Completion date
NCT03174275 Active, not recruiting Phase 2 Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma December 19, 2017 February 2, 2027
NCT03082534 Active, not recruiting Phase 2 Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma March 28, 2017 May 2024
NCT02586207 Active, not recruiting Phase 1 Pembrolizumab in Combination With CRT for LA-SCCHN November 2015 September 2024
NCT05217147 Completed An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma May 1, 2018 August 31, 2021
NCT04778306 Completed N/A Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell Cancer January 1, 2010 December 31, 2019
NCT00169247 Completed Phase 2 Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation October 2005
NCT00359645 Completed Phase 3 Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population June 21, 2006 December 18, 2015
NCT00600223 Completed Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches October 2005 October 2010
NCT06129487 Completed N/A Evaluations of Alcohol Warning Labels January 19, 2024 March 27, 2024
NCT01045057 Completed N/A Clinical Feasibility of New Tracheoesophageal Puncture Set December 2009 April 2011
NCT05746780 Completed Bilateral Elective Neck Dissection in Salvage Total Laryngectomy September 1, 2020 March 1, 2021
NCT01084733 Completed Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer August 2007 June 30, 2019
NCT01700647 Completed Breath Testing in Early and Late Larynx Cancer October 2012 October 2014
NCT03028766 Completed Phase 1 WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer June 22, 2017 February 3, 2021
NCT03096808 Completed Phase 2 Adaptive Radiotherapy for Head and Neck Cancer March 15, 2017 October 22, 2021
NCT03292341 Completed N/A Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients. September 2015 December 31, 2016
NCT05497947 Completed Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy July 3, 2021 July 3, 2023
NCT03602079 Completed Phase 1/Phase 2 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene July 16, 2018 January 12, 2022
NCT03653039 Completed N/A Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy September 12, 2018 February 14, 2019
NCT00160095 Completed Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas July 2001 March 2013
NCT00158652 Completed Phase 3 Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC March 2000 March 2011
NCT00162708 Completed Phase 2/Phase 3 Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC July 1996
NCT00169182 Completed Phase 3 Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma December 15, 2001 May 2009
NCT05793151 Recruiting N/A Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy October 30, 2023 March 30, 2028
NCT03759431 Recruiting Phase 2 Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer October 11, 2018 July 12, 2026
NCT03942380 Recruiting N/A Cell-free Tumor DNA in Head and Neck Cancer Patients February 1, 2017 February 1, 2025
NCT04028479 Recruiting The Registry of Oncology Outcomes Associated With Testing and Treatment May 5, 2021 October 1, 2031
NCT04057209 Recruiting N/A VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer November 20, 2019 November 30, 2029
NCT05337631 Recruiting Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy June 1, 2021 December 31, 2023
NCT05561920 Recruiting Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients August 1, 2022 October 2024
NCT05798780 Recruiting N/A The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors April 6, 2023 January 2025
NCT06016699 Recruiting Immunological Function After Radiation With Either Proton or Photon Therapy September 23, 2021 April 1, 2024
NCT06039631 Recruiting Phase 2 Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer August 22, 2023 September 1, 2029
NCT06086119 Recruiting Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers May 4, 2021 May 4, 2024
NCT04368702 Suspended N/A CONFIRM: Magnetic Resonance Guided Radiation Therapy May 1, 2021 June 18, 2024
NCT00080028 Terminated Phase 1 Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
NCT03479463 Terminated Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy March 19, 2018 March 30, 2019
NCT00965003 Terminated Early Phase 1 MRI Laryngeal Imaging With a Surface Coil July 2009 January 2010
NCT01073683 Unknown status Phase 2 Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer April 2010 December 2014
NCT05471401 Withdrawn N/A GI Organ Tracking Via Balloon Applicators April 25, 2023 May 31, 2025
NCT04892875 Withdrawn Phase 1 A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers December 31, 2023 December 2026
Disase is a (Disease Ontology)
DOID:0050615
Cross Reference ID (Disease Ontology)
GARD:6862
Cross Reference ID (Disease Ontology)
ICD10CM:C32
Cross Reference ID (Disease Ontology)
ICD9CM:161
Cross Reference ID (Disease Ontology)
MESH:D007822
Cross Reference ID (Disease Ontology)
NCI:C7484
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:93859007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0007107